Author
Kiana Shirani, Rasool Soltani, Yasaman Eskandari, Hasan Salehi
Publication Date
1401
Publication Place
-
Isfahan University of Medical Sciences, 1401.
Subject
ascorbic acid, mortality, procalcitonin, sepsis, thiamine, Medicine, Medicine (General), R5-920
Type
Periodical
Language
Persian
Digital
Yes
Manuscript
No
Physical Dimensions
electronic resource
Library
Bursa Uludağ University Library
Library Asset ID
edsdoj.7314461cebbe4879a120d29e010f984d
Record ID
cyeo6zyufb
Library Location
LCC:Medicine, LCC:Medicine (General)
Date
1401
Sample Text
Background: Sepsis is a potentially life-threatening condition characterized by the body's deregulated response to infection, in turn causing injury to its own tissues and organs. The present study investigated the effect of co-administration of thiamine and vitamin C on reducing mortality in patients with severe sepsis.Methods: In this randomized clinical trial study, 86 patients with severe sepsis were assigned to treatment and control groups, each comprising 43 patients. The treatment group received thiamine 600 mg orally every 12 hours and vitamin C at a dose of 50 mg / kg, intravenously daily for 96 hours alongside standard treatment and the control group received standard treatment. Therapeutic outcome (recovery or death), duration of hospitalization and duration of ventilator connection were recorded for patients in both groups. Also, procalcitonin level (PCT) and CRP levels were measured and recorded at the beginning and after 96 hours.Findings: The odds ratio of death outcome in the treatment group was significantly lower than the control group (0.913-0.116: 95% CI, P = 0.033, OR = 0.32). The mean length of hospital stay in the treatment group was about 7 days that was less than the control group significantly. The mean length of ICU hospitalization in the treatment group was less than the control group significantly too.Conclusion: Co-administration of vitamin C and thiamine in sepsis patients can reduce the length of hospital stay in the intensive care unit and hospital and also reduce the serum level of inflammatory factors and reduce the rate of death in these patients.
DOI
10.48305/jims.v40.i691.0825
ISSN
1027-7595, 1735-854X
İlişki
https://jims.mui.ac.ir/article_26275_713b521d4d5b06f9cda40ebb149b0d5e.pdf; https://doaj.org/toc/1027-7595; https://doaj.org/toc/1735-854X